Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary
KEYWORDS: iiia, iib, iib iiia, patients, pci, inhibitors, iiia inhibitors, acs, use, management, treatment, risk, coronary, cost, inhibitor

syndromes 1 Recommendations 1.1 This recommendation no longer stands. 1.2 This recommendation has been updated and replaced by recommendation 1.1.5 in the NICE guideline on acute coronary syndromes. 1.3 This recommendation has been updated and replaced by recommendation 1.1.5 in the NICE guideline on acute coronary syndromes. 1.4 This recommendation has been updated and replaced by recommendations 1.2.7 and 1.2.8 in the NICE guideline on acute coronary syndromes. 1.5 This recommendation no longer stands. 1.6 This recommendation no longer stands.
